NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Shorts short to keep the price down, so their mark-to-market naked/legal short liabilities don't blow up in their face. It will blow up on them regardless, very soon, and upon approval, but the shorts are trying to manage that. That is the basic premise. Your response of why shorts would continue to short and statements that they do short as defying logic seems to be an insincere response.

But I do understand why shorts would not want the shorting topic to go on right before MHRA approval. It is because that opens up the awareness and possibility for a major short squeeze to happen. That is the short's worse fear. That fear was also my response to the original question of "Why would they be keeping price down for a buyout?" To be clear though and as a long investor, shorting is a secondary or third level matter of importance as well, as MHRA approval and adoption are the key drivers going forward.